D'Silva Andrew J. bought OPRX
August 21, 2025 · Form 4 insider transaction
D'Silva Andrew J. bought 10,417 shares of OptimizeRx Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 47 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,417
Price
$0.00
Total value
N/A
InsiderD'Silva Andrew J.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 21, 2025
Filing dateOctober 7, 2025
Shares owned after47,514
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.